2m 2m 2m 2m 2m 2m 2m
LARIMAR THERAP (LRMR)
NASDAQ
$2.97-$0.09 (-2.94%)
Price as of Oct 02, 2026 4:30 PM EDT- $317.9MMarket Cap
- -28.50%1-Year Change
- BiotechnologyIndustry
LARIMAR THERAP (LRMR)
$2.97-$0.09 (-2.94%)
LRMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.06 | ||
Change | -$0.13 (-4.23%) | ||
Open | $3.20 | ||
High | $3.20 | ||
Low | $3.04 | ||
Previous Close | $3.19 | ||
Volume | 858,311 | ||
30-Day Average Volume | 1,360,481 | ||
1-Week Change | -7.83% | ||
1-Month Change | -22.34% | ||
1-Year Change | -28.50% | ||
3-Year Change | -22.53% | ||
5-Year Change | -73.16% | ||
Fundamentals | |||
Shares Outstanding | 103.9M | ||
Total Assets | $165.3M | ||
Market Cap | $317.9M | ||
Enterprise Value | $225.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.8M | ||
Free Cash Flow | -$44.1M | ||
EBIT | -$32.8M | ||
EBITDA | -$32.7M | ||
Net Working Capital | $126.5M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | 10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue